KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

ABRAMS CAPITAL MANAGEMENT, L.P.'s Holding History (CIK: 0001358706)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 9,108,867 Value ($000) $30,970 Avg Close — Range —
Q2 2018
Shares 9,950,055 Value ($000) $37,412 Avg Close — Range —
Q1 2018
Shares 9,719,176 Value ($000) $39,751 Avg Close — Range —
Q4 2017
Shares 9,719,176 Value ($000) $45,194 Avg Close — Range —
Q3 2017
Shares 5,719,176 Value ($000) $40,606 Avg Close — Range —
Q2 2017
Shares 5,719,176 Value ($000) $41,350 Avg Close — Range —
Q1 2017
Shares 5,719,176 Value ($000) $35,230 Avg Close — Range —
Q4 2016
Shares 5,719,176 Value ($000) $33,514 Avg Close — Range —
Q3 2016
Shares 5,719,176 Value ($000) $30,369 Avg Close — Range —
Q2 2016
Shares 5,719,176 Value ($000) $37,861 Avg Close — Range —
Q1 2016
Shares 5,719,176 Value ($000) $26,709 Avg Close — Range —
Q4 2015
Shares 5,500,000 Value ($000) $27,775 Avg Close — Range —
Q3 2015
Shares 5,000,000 Value ($000) $17,600 Avg Close — Range —